The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of the program’s price negotiations, touting a total of $12 billion saved compared to last year’s spending. The medications include widely used cancer and diabetes drugs, inhalers, and GLP-1 medications Ozempic and Wegovy — the drugs Medicare spends the most on. The negotiated…
